Why the study?
Pre-implant eligibility for an S-ICD relies on automated screening tool (AST) vector screening, prompting investigation into standard 12-lead ECG characteristics to determine eligibility and avoid AST screening.
Does a standard 12-lead ECG screening model predict eligibility for a subcutaneous defibrillator in patients at risk for sudden cardiac death?
Does a standard 12-lead ECG screening model predict eligibility for a subcutaneous defibrillator in patients at risk for sudden cardiac death?
Answers are grounded in this paper and cite their sources.
A simple 3-criteria model using a standard 12-lead ECG can accurately predict S-ICD eligibility, potentially obviating the need for additional AST screening in a subset of patients.
BACKGROUND: Currently, the eligibility for a subcutaneous implantable defibrillator (S-ICD) system relies on a pre-implant vector screening based on the automated screening tool (AST). We investigated which 12-lead ECG characteristics are associated with eligibility for an S-ICD in a heterogeneous population at risk for sudden cardiac death (SCD). The goal is to determine patient eligibility for S-ICD using the standard 12-lead ECG, thereby avoiding additional AST screening. METHODS: We evaluated the eligibility for an S-ICD in 254 consecutive patients at risk for SCD. We identified 12-lead ECG parameters which were independently associated with AST passing (≥1 vector) using multivariable logistical regression analysis in our derivation cohort. The final model was tested in a separate validation cohort. RESULTS: The overall passing rate was 92% in our derivation cohort. Independent 12-lead ECG characteristics associated with AST passing were QRS ≤ 130 ms, absence of QRS/T discordance in lead II and R/T-ratio ≥3.5 in lead II. Eighty-three of 254 patients (33%) fulfilled these three criteria and had a passing rate of 100%. Of the validation cohort, 37 of 60 patients (62%) fulfilled all three criteria and also had a passing rate of 100%. The interobserver agreement for applying the ECG model was 90% (Cohen's Kappa = 0.80). CONCLUSION: Using the standard 12-lead ECG, we developed a simple screening model with a high specificity for S-ICD eligibility. Our results suggest that patients who fulfill the three ECG criteria do not need additional AST-screening.
No takes yet. Share an insight, caveat, or question.
Sakhi et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: